← Back to Search

Cardiac Rehabilitation for Stroke Survivors (SRP-CROSS Trial)

N/A
Recruiting
Led By Sara J Cuccurullo, MD
Research Sponsored by Hackensack Meridian Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-year post stroke
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if a cardiac rehabilitation program can help stroke patients recover better. It aims to see if these patients have fewer hospital visits, fewer repeat strokes, and lower death rates by adding this program to their usual care.

Who is the study for?
This trial is for stroke survivors who are 18 or older, can follow commands and communicate discomfort, have been admitted to a rehab facility post-stroke, and cleared by a cardiologist. They must be able to stand and walk at least 10 feet with assistance if needed. Those with certain other brain conditions or medical issues that prevent participation in the study, unable to meet study requirements, non-English speakers, or diagnosed beyond 45 days post-stroke are excluded.
What is being tested?
The SRP-CROSS trial is testing whether adding cardiac rehabilitation to standard care helps improve recovery after a stroke. It looks at whether this approach reduces hospital readmissions, recurrent strokes, and death rates among these patients.
What are the potential side effects?
While specific side effects aren't listed for cardiac rehabilitation programs in this summary, such interventions may include general risks like muscle soreness or fatigue from exercise. The program should be tailored to each patient's abilities following their stroke.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-year post stroke
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-year post stroke for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
6-Minute Walk Test (6MWT)
Secondary study objectives
10-Minute Walk Test (10MWT)
AM-PAC - (Activity Measure for Post Acute Care)
All-cause hospital readmission
+8 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cardiac rehabilitation groupExperimental Treatment1 Intervention
Traditional medically supervised center-based cardiac rehabilitation program; including 36 sessions (30-50 minutes) of a progressive exercise program and educational sessions for cardiovascular disease (CVD) risk factors.
Group II: Standard of careActive Control1 Intervention
Depending on functional deficits, conventional rehabilitation therapies can include physical therapy, occupational therapy, and/or speech therapy sessions with 2-3 visits per week. Participants will receive their standard of care therapies as prescribed by their treating physicians.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Cardiac rehabilitation programs for stroke patients typically include structured exercise, education, and counseling. Structured exercise helps improve cardiovascular health by enhancing blood flow, reducing blood pressure, and increasing overall physical endurance, which can mitigate the risk of recurrent strokes. Education provides patients with knowledge about stroke risk factors, healthy lifestyle choices, and medication adherence, empowering them to manage their health proactively. Counseling offers psychological support, helping patients cope with the emotional aftermath of a stroke and encouraging adherence to rehabilitation protocols. Together, these components work synergistically to enhance recovery, reduce hospital readmissions, and lower mortality rates, making them vital for stroke patients.

Find a Location

Who is running the clinical trial?

Hackensack Meridian HealthLead Sponsor
135 Previous Clinical Trials
30,210 Total Patients Enrolled
1 Trials studying Stroke
12 Patients Enrolled for Stroke
The Cardiovascular Institute of New Jersey at Rutgers Robert Wood Johnson Medical SchoolUNKNOWN
Sara J Cuccurullo, MDPrincipal InvestigatorHackensack Meridian Health - JFK Johnson Rehabilitation Institute

Media Library

Cardiac rehabilitation group Clinical Trial Eligibility Overview. Trial Name: NCT05651945 — N/A
Stroke Research Study Groups: Cardiac rehabilitation group, Standard of care
Stroke Clinical Trial 2023: Cardiac rehabilitation group Highlights & Side Effects. Trial Name: NCT05651945 — N/A
Cardiac rehabilitation group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05651945 — N/A
~40 spots leftby Jan 2026